JAIME RECASENS: Open Payments
NPI 1659365195 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 9 payments from 6 companies in 2025. Trend: 2023 $913 · 2024 $403 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Medtronic, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Indivior Inc. | 1 | $15 |
Products named: Kerendia, CAPLYTA, INTELLIS ADAPTIVESTIM, VOQUEZNA, FARXIGA, SUBLOCADE.
Industry payments across GA — which companies pay providers there.
